Blue Cross and Blue Shield has announced a partnership with Onduo, an Alphabet-backed wearable device for the monitoring of glucose levels in diabetic patients.

A year after the launch of Onduo by Alphabet, with the aim to produce technologies for the improved self-management of diabetes, the partnership with Blue Cross will provide individuals the ability to improve health outcomes with the technology.

“We’re working on finding those innovations in the market that will move the needle and improve our (health plan) members' lives,” said Maureen Sullivan, Blue Cross and Blue Shield Association senior vice president and chief strategy officer.

Read the full story below: